GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BIMI Holdings Inc (STU:63N) » Definitions » Gross Profit

BIMI Holdings (STU:63N) Gross Profit : €4.73 Mil (TTM As of Sep. 2023)


View and export this data going back to . Start your Free Trial

What is BIMI Holdings Gross Profit?

BIMI Holdings's gross profit for the three months ended in Sep. 2023 was €0.11 Mil. BIMI Holdings's gross profit for the trailing twelve months (TTM) ended in Sep. 2023 was €4.73 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. BIMI Holdings's gross profit for the three months ended in Sep. 2023 was €0.11 Mil. BIMI Holdings's Revenue for the three months ended in Sep. 2023 was €2.36 Mil. Therefore, BIMI Holdings's Gross Margin % for the quarter that ended in Sep. 2023 was 4.57%.

BIMI Holdings had a gross margin of 4.57% for the quarter that ended in Sep. 2023 => No sustainable competitive advantage

During the past 13 years, the highest Gross Margin % of BIMI Holdings was 40.30%. The lowest was 2.47%. And the median was 15.68%.


BIMI Holdings Gross Profit Historical Data

The historical data trend for BIMI Holdings's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BIMI Holdings Gross Profit Chart

BIMI Holdings Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 2.01 2.15 1.84

BIMI Holdings Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.71 0.38 1.58 2.66 0.11

Competitive Comparison of BIMI Holdings's Gross Profit

For the Pharmaceutical Retailers subindustry, BIMI Holdings's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BIMI Holdings's Gross Profit Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, BIMI Holdings's Gross Profit distribution charts can be found below:

* The bar in red indicates where BIMI Holdings's Gross Profit falls into.



BIMI Holdings Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

BIMI Holdings's Gross Profit for the fiscal year that ended in Dec. 2022 is calculated as

Gross Profit (A: Dec. 2022 )=Revenue - Cost of Goods Sold
=11.168 - 9.327
=1.84

BIMI Holdings's Gross Profit for the quarter that ended in Sep. 2023 is calculated as

Gross Profit (Q: Sep. 2023 )=Revenue - Cost of Goods Sold
=2.364 - 2.256
=0.11

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €4.73 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

BIMI Holdings's Gross Margin % for the quarter that ended in Sep. 2023 is calculated as

Gross Margin % (Q: Sep. 2023 )=Gross Profit (Q: Sep. 2023 ) / Revenue (Q: Sep. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.11 / 2.364
=4.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


BIMI Holdings  (STU:63N) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

BIMI Holdings had a gross margin of 4.57% for the quarter that ended in Sep. 2023 => No sustainable competitive advantage


BIMI Holdings Gross Profit Related Terms

Thank you for viewing the detailed overview of BIMI Holdings's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


BIMI Holdings (STU:63N) Business Description

Traded in Other Exchanges
Address
Chongqing Corporation Avenue, 9th Floor, Building 2, Yuzhong District, Chongqing, CHN, 400010
BIMI International Medical Inc is a healthcare product and provider, offering a broad range of healthcare products and related services and operates private hospitals in China. The company is engaged in four business segments, Pharmaceuticals wholesale, Medical devices wholesale, Medical services, and Pharmacy retail. It generates maximum revenue from the pharmaceuticals wholesale segment. It mainly sources its products from large state-owned pharmaceutical manufacturers and wholesalers and mid-sized or small private pharmaceutical manufacturers and wholesalers. The Company's revenues were generated in the PRC.

BIMI Holdings (STU:63N) Headlines

No Headlines